Skip to content

Assessing the effect of thyme-honey nasal spray on chronic rhinosinusitis

Assessing the effect of thyme-honey nasal spray on chronic rhinosinusitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT201204303186N2
Enrollment
60
Registered
2012-12-05
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis. Chronic sinusitis

Interventions

intervention group: thyme honey/ spray/ twice a day/ 3 puffs each nasal cavity control group: distilled water/ spray/ twice a day/ 3 puffs each nasal cavity.
Treatment - Drugs
intervention group: thyme honey/ spray/ twice a day/ 3 puffs each nasal cavity control group: distilled water/ spray/ twice a day/ 3 puffs each nasal cavity

Sponsors

Hamedan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: patients referred to Besat Hospital clinic with chronic rhinosinusitis ( according to AAO-HNS) who have not responded to medical therapy and are candidated for FESS. Exclusion criteria: age under 18 years and above 65 years; hypersensitivity to honey, pollen, thyme, bees; systemic diseases such as cystic fibrosis, immotile cilia syndrome, granulomatous diseases and diabetus mellitus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chronic rhinosinusitis. Timepoint: before, 1 week, 1 month, 2 months after intervention. Method of measurement: Snot-22 questionnaire, CT-scan score, Philpott-Javer endoscopic score.

Secondary

MeasureTime frame
Hypersensitivity. Timepoint: 1 week, 1 month and 2 months after intervention. Method of measurement: questionnaire, physical examination.;Burning sensation. Timepoint: 1 week, 1 month, 2 months after intervention. Method of measurement: questionnaire.;Epistaxis. Timepoint: 1 week, 1 month and 2 months after intervention. Method of measurement: questionnaire, physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Hashemian

Hamedan university of medical sciences

hashemian@umsha.ac.ir+98 81 1264 0047

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026